To: | Alkaline 88, LLC (ptodocket.us.dbg@dentons.com) |
Subject: | U.S. Trademark Application Serial No. 88976611 - SOOTHE - 130502000011 |
Sent: | October 08, 2020 04:45:54 PM |
Sent As: | ecom109@uspto.gov |
Attachments: |
United States Patent and Trademark Office (USPTO)
Office Action (Official Letter) About Applicant’s Trademark Application
U.S. Application Serial No. 88976611
Mark: SOOTHE
|
|
Correspondence Address: |
|
Applicant: Alkaline 88, LLC
|
|
Reference/Docket No. 130502000011
Correspondence Email Address: |
|
NONFINAL OFFICE ACTION
The USPTO must receive applicant’s response to this letter within six months of the issue date below or the application will be abandoned. Respond using the Trademark Electronic Application System (TEAS). A link to the appropriate TEAS response form appears at the end of this Office action.
Issue date: October 08, 2020
Applicant’s response of September 22, 2020 to the office action of March 28, 2020, has been reviewed and the following determinations have been made.
Upon further consideration, the Section 2d refusal is withdrawn. The Request for Information is satisfied. The identification as amended is accepted.
The CSA and FDCA refusals are continued because applicant’s response contains conflicting statements that require clarification. Applicant should also note the new requirement for additional information.
Summary of Issues:
· CONTINUED: CSA Refusal
· CONTINUED: FDCA Refusal
· NEW: Request for Information
CSA REFUSAL (continued)
Applicant’s arguments have been considered and the refusal is continued for the following reasons.
In applicant’s September 22, 2020 response to office action, applicant amended the identification of goods to include the statement that “none of the aforementioned goods containing cannabis or cannabis extracts including CBD.”
In the same response, applicant responded to the Request for Information (RFI) stating that “Yes, the goods will contain extracts from industrial hemp” and “No” to the question of whether the goods contain CBD.
Applicant’s amendment to the identification and responses to the RFI are inconsistent. “Cannabis” is a broad term that encompasses both hemp (which is cannabis with a THC concentration of 0.3% or less on a dry weight basis) and marijuana (which is cannabis with a THC concentration of more than 0.3% on a dry weight basis). Thus, the admission that the goods will contain “extracts from hemp” and the statement in the identification that the goods do not contain cannabis are inconsistent. Applicant must clarify this inconsistency.
Identification of Goods: Applicant is advised that in order for the proposed amendment to the identification to overcome the CSA refusal, the comma that precedes the word “none” must be replaced with a semi-colon, so that the limitation applies to all of the preceding goods, not just the “purified bottled drinking water”.
In addition, if the goods contain hemp, but no CBD, applicant may amend the identification to clarify, for example:
Water beverages; drinking water; bottled water; bottled drinking water; purified bottled drinking water; all of the foregoing goods containing hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3% on a dry weight basis and none of the foregoing containing any cannabidiol (CBD).
Filing Date: In order to overcome the CSA refusal, applicant still needs to request that the Office amend the filing date to December 20, 2018, the date on which the Agriculture Improvement Act was signed into law.
Applicant is advised that if the application is amended as suggested above, the CSA refusal will be withdrawn. Applicant is further advised, that any future specimen must show the goods as described in the identification or the refusal with be reinstated. Applicant is also advised that the Date of First Use in Commerce in any future Statement of Use (or Amendment to Allege Use) cannot be earlier than December 20, 2018.
FDCA REFUSAL (continued)
The FDCA refusal is also continued for the reasons stated above (incorporated herein by reference). Specifically, applicant’s responses to the Request for Information appear to be inconsistent with the amendment to the identification. Applicant must clarify these inconsistencies.
If the goods contain hemp extracts without any cannabidiol (CBD) cannabinoids, then applicant may adopt the identification as suggested above and the refusal will be withdrawn. However, the same requirements (and advisories) set forth in the section above apply in order for the FDCA refusal to be withdrawn.
REQUEST FOR INFORMATION
To permit proper examination of the application, applicant must submit additional information about applicant’s goods and/or services. See 37 C.F.R. §2.61(b); TMEP §§814, 1402.01(e).
In this case, the record contains inconsistencies that require clarification. Specifically, in applicant’s September 22, 2020 response to office action, applicant amended the identification of goods to include the statement that “none of the aforementioned goods containing cannabis or cannabis extracts including CBD.” At the same time, applicant responded to the Request for Information (RFI) stating that “Yes, the goods will contain extracts from industrial hemp” and “No” to the question of whether the goods contain CBD.
The term “cannabis” refers to (and includes) both hemp (which is cannabis with a THC concentration of 0.3% or less on a dry weight basis) and marijuana (which is cannabis with a THC concentration of more than 0.3% on a dry weight basis). Thus, the admission that the goods will contain “extracts from hemp” and the statement in the identification that the goods do not contain cannabis are inconsistent. Additional information is required to clarify this inconsistency.
Applicant must respond to the following:
1. If the goods contain hemp extract, does the hemp extract contain any cannabinoids?
2. If applicant answered “yes” to question #1, do the cannabinoids in the hemp extract include cannabidiol (CBD)?
3. Do or will the goods contain more than a trace amount of cannabidiol (CBD)?
4. In what form are/will the “extracts from industrial hemp” be added to the goods, e.g., liquid, powder, etc.?
5. Does/will applicant have any documentation showing the cannabinoid profile of the hemp in the goods?
How to respond. Click to file a response to this nonfinal Office action.
/Deborah Lobo/
Trademark Examining Attorney
Law Office 109
571-272-3263
deborah.lobo@uspto.gov
RESPONSE GUIDANCE